References
- RoskellNSAnzuetoAHamiltonADisseBBeckerKOnce-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterolInt J Chron Obstruct Pulmon Dis2014981382425114521
- FeldmanGJHamiltonJANivensMCKorduckiLLaForceCThe 24-h FEV1 Time Profile of Olodaterol Once Daily via Respimat® and Formoterol Twice Daily via Aerolizer® in Patients with GOLD 2–4 COPD: Results from Two 6-week Crossover StudiesSpringer Plus2014341925187881
- LangePHamiltonATetzlaffKTingNDeromEThe 24-hour lung function time profile of olodaterol once daily versus placebo and tiotropium in patients with moderate to very severe chronic obstructive pulmonary diseaseJ Pulm Respir Med20144196
- KornSKerwinEAtisSIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med2011105571972621367594
- MahlerDAD’UrzoABatemanEDConcurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonThorax201267978178822544891
- KinoshitaMLeeSHHangLWEfficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled studyRespirology201217237938922122202
- Center for Drug Evaluation and Research summary review document for indacaterol2011Study B2354 Available from http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022383Orig1s000ClinPharmR.pdfAccessed August 29, 2014
- CopeSCapkun-NiggliGGaleRJardimJRJansenJPComparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysisInt J Chron Obstruct Pulmon Dis2011632934421697997
- CopeSZhangJWilliamsJJansenJPEfficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisBMC Pulm Med2012122922732017
- FergusonGTFeldmanGJHofbauerPEfficacy and safety of olodaterol once daily delivered via Respimat(R) in patients with GOLD 2–4 COPD: results from two replicate 48-week studiesInt J Chron Obstruct Pulmon Dis2014962964524966672
- KochAPizzichiniEHamiltonALung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat(R) versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studiesInt J Chron Obstruct Pulmon Dis2014969771425045258
- Center for Drug Evaluation and Research summary review document for indacaterol2011Study B2355 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022383Orig1s000TOC.cfmAccessed September 2, 2014
- BeierJChanezPMartinotJBSafety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trialPulm Pharmacol Ther200720674074917088091
- BuhlRDunnLJDisdierCBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPDEur Respir J201138479780321622587
- DahlRChungKFBuhlREfficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPDThorax201065647347920522841
- DonohueJFFogartyCLotvallJOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
- FeldmanGSilerTPrasadNEfficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyBMC Pulm Med2010101120211002
- KornmannODahlRCentanniSOnce-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparisonEur Respir J201137227327920693243
- Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD2010 http://www.goldcopd.org/uploads/users/files/GOLDReport_April112011.pdfAccessed dd, mm, yyyy
References
- RoskellNSAnzuetoAHamiltonADisseBBeckerKOnce-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterolInt J Chron Obstruct Pulmon Dis2014981382425114521
- KornSKerwinEAtisSIndacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week studyRespir Med2011105571972621367594
- BuhlRDunnLJDisdierCBlinded 12-week comparison of once-daily indacaterol and tiotropium in COPDEur Respir J201138479780321622587
- KinoshitaMLeeSHHangLWEfficacy and safety of indacaterol 150 and 300 μg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled studyRespirology201217237938922122202